Remove 2006 Remove Immunization Remove Vaccines
article thumbnail

HIV vaccines suffer setbacks but new approaches could turn the tide

Pharmaceutical Technology

Only a few weeks into the new year, the prospect of getting a successful advanced HIV vaccine shrank after the discontinuation of yet another late-stage trial. On January 18, Janssen, a Johnson & Johnson (J&J) subsidiary, stated that its vaccine was not effective in preventing HIV infections.

Vaccines 117
article thumbnail

Methylprednisolone interactions to avoid

The Checkup by Singlecare

Key takeaways: Methylprednisolone is an effective therapeutic agent to control immune responses and inflammation. Sources Effects of oral corticosteroids on chronic warfarin therapy , The Annals of Pharmacotherapy (2006) Corticosteroids and ulcers: is there an association ?,

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Biotech Effect

Pharmaceutical Technology

.” By the early 2000s AstraZeneca had already realised the critical importance of biotechnology, making a number of strategic investments in biotech companies, Abgenix in 2003, Cambridge Antibody Technology in 2006 and culminating in its acquisition of US biotech firm, Medimmune in April 2007 for £15bn.

article thumbnail

Top 20 Radiopharma Companies Based on Market Cap

PharmaShots

Nordic is advancing the development of CD37-targeted therapies for hematological cancers and immune diseases. Under its cancer therapy products, the company develops low molecular drugs, antibody drugs, cancer peptide vaccines, and diagnostic medicines.

FDA 56